X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   ADCOCK INGRAM
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ADCOCK INGRAM
Jun-14
FDC LTD./
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs144399-   
Low Rs79288-   
Sales per share (Unadj.) Rs47.6118.6-  
Earnings per share (Unadj.) Rs7.6-29.9-  
Cash flow per share (Unadj.) Rs9.0-24.8-  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.593.1-  
Shares outstanding (eoy) m177.83168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.32.9 80.8%   
Avg P/E ratio x14.6-11.5 -127.3%  
P/CF ratio (eoy) x12.3-13.9 -89.1%  
Price / Book Value ratio x2.33.7 63.5%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78457,925 34.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,2213,636 33.6%   
Avg. sales/employee Rs ThNM4,663.4-  
Avg. wages/employee Rs ThNM846.8-  
Avg. net profit/employee Rs ThNM-1,175.1-  
INCOME DATA
Net Sales Rs m8,45920,020 42.3%  
Other income Rs m394140 280.7%   
Total revenues Rs m8,85220,160 43.9%   
Gross profit Rs m2,070-3,469 -59.7%  
Depreciation Rs m249864 28.8%   
Interest Rs m31542 5.7%   
Profit before tax Rs m2,184-4,736 -46.1%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606296 204.6%   
Profit after tax Rs m1,353-5,045 -26.8%  
Gross profit margin %24.5-17.3 -141.2%  
Effective tax rate %27.7-6.2 -443.8%   
Net profit margin %16.0-25.2 -63.5%  
BALANCE SHEET DATA
Current assets Rs m4,35514,663 29.7%   
Current liabilities Rs m1,7928,250 21.7%   
Net working cap to sales %30.332.0 94.6%  
Current ratio x2.41.8 136.8%  
Inventory Days Days44111 40.1%  
Debtors Days Days25124 19.9%  
Net fixed assets Rs m3,0258,547 35.4%   
Share capital Rs m17993 192.1%   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,45315,714 53.8%   
Long term debt Rs m115,522 0.2%   
Total assets Rs m10,55729,684 35.6%  
Interest coverage x71.4-7.7 -923.6%   
Debt to equity ratio x00.4 0.4%  
Sales to assets ratio x0.80.7 118.8%   
Return on assets %13.1-15.2 -86.4%  
Return on equity %16.0-32.1 -49.9%  
Return on capital %23.5-19.8 -118.7%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,4851,709 86.9%  
From Investments Rs m-620-525 118.1%  
From Financial Activity Rs m-7535,012 -15.0%  
Net Cashflow Rs m1136,196 1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.5 Rs / ZAR

Compare FDC LTD. With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare FDC LTD. With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  STRIDES SHASUN LTD  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - GLENMARK PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS